LITTLE FALLS, N.J.,
Sept. 26, 2016 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE: CMN), a leading global
company dedicated to delivering innovative infection prevention
products and services, today announced that the Company has
expanded its direct sales operations in Canada by acquiring endoscope reprocessing
business assets from its Canadian distributor, Vantage Endoscopy,
Inc., a subsidiary of Diploma Canada Holdings Ltd. The endoscope
reprocessing business consists of Cantel's
Medivators®-branded automated endoscope reprocessors,
chemistries, consumables and a full sales and service
organization.
Jorgen B. Hansen, President and
CEO of Cantel Medical said, "This acquisition is consistent with
Cantel's strategy to expand its products and services into key
markets to provide global solutions that meet local needs. We are
pleased to be able to offer customers an expanded
Medivators®-branded product portfolio while providing
the same level of high-quality service and support they have always
received. We look forward to continuing these relationships and
partnering with them in the future."
"The expansion of our commercial platform and the addition of a
direct sales and service organization for our Endoscopy business
will further strengthen Cantel's share in the infection prevention
market in Canada." stated
Michael Spicer, President, Americas
Sales, UK, Canada, Latin America and Global Service. "Expanding
our presence in the Canadian market will enable us to realize the
full potential of our portfolio while also enabling us to offer a
broader suite of infection prevention products from all Cantel
divisions."
About Cantel Medical
Cantel Medical is a leading global company dedicated to
delivering innovative infection prevention products and services
for patients, caregivers, and other healthcare providers which
improve outcomes, enhance safety and help save lives. Our
products include specialized medical device reprocessing systems
for endoscopy and renal dialysis, advanced water purification
equipment, sterilants, disinfectants and cleaners, sterility
assurance monitoring products for hospitals and dental clinics,
disposable infection control products primarily for dental and GI
endoscopy markets, dialysate concentrates, hollow fiber membrane
filtration and separation products. Additionally, we provide
technical service for our products.
For further information, visit the Cantel website at
www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cantel-medical-expands-its-direct-sales-operations-in-canada-through-the-acquisition-of-its-endoscopy-assets-from-vantage-endoscopy-300334004.html
SOURCE Cantel Medical Corp.